Stockreport

AgeX Therapeutics Issues Year-End Letter to Shareholders

AgeX Therapeutics, Inc.  (AGE) 
PDF ALAMEDA, Calif.--(BUSINESS WIRE)--AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company focused on developing therapeutics for human aging an [Read more]